Lmr Partners LLP Bei Gene, Ltd. Transaction History

Lmr Partners LLP

$10.9 Billion
Q3 2024

A detailed history of Lmr Partners LLP transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Lmr Partners LLP holds 6,838 shares of BGNE stock, worth $1.22 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,838

Holding current value

$1.22 Million

% of portfolio

0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$143.93 - $224.51 $984,193 - $1.54 Million	6,838 New	6,838 $1.54 Million
Q1 2024 May 15, 2024	BUY	$141.8 - $181.47 $2.2 Million - $2.82 Million	15,520 Added 451.95%	18,954 $2.96 Million
Q4 2023 Feb 14, 2024	SELL	$158.67 - $201.58 $1.66 Million - $2.11 Million	-10,447 Reduced 75.26%	3,434 $619,000
Q3 2023 Nov 14, 2023	BUY	$179.87 - $225.13 $2.5 Million - $3.13 Million	13,881 New	13,881 $2.5 Million
Q2 2022 Aug 15, 2022	BUY	$121.11 - $216.05 $1.59 Million - $2.83 Million	13,108 New	13,108 $2.12 Million
Q1 2022 May 16, 2022	SELL	$146.52 - $269.56 $869,010 - $1.6 Million	-5,931 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$248.56 - $389.34 $1.02 Million - $1.61 Million	-4,123 Reduced 41.01%	5,931 $1.61 Million
Q3 2021 Nov 15, 2021	BUY	$249.6 - $403.14 $2.51 Million - $4.05 Million	10,054 New	10,054 $3.65 Million
Q2 2020 Aug 14, 2020	SELL	$123.9 - $195.41 $1.51 Million - $2.38 Million	-12,159 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$115.78 - $208.34 $733,003 - $1.32 Million	6,331 Added 108.63%	12,159 $2.02 Million
Q3 2019 Nov 14, 2019	BUY	$120.61 - $148.29 $702,915 - $864,234	5,828 New	5,828 $714,000

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$1.88 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.14 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$920 Million
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$884 Million
0.84% of portfolio
Baillie Gifford & CO

3.71M
Shares

$659 Million
0.64% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.4B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Account